Product NDC: | 60432-093 |
Proprietary Name: | Amantadine Hydrochloride |
Non Proprietary Name: | AMANTADINE HYDROCHLORIDE |
Active Ingredient(s): | 50 mg/5mL & nbsp; AMANTADINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60432-093 |
Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075060 |
Marketing Category: | ANDA |
Start Marketing Date: | 19981224 |
Package NDC: | 60432-093-16 |
Package Description: | 473 mL in 1 BOTTLE, PLASTIC (60432-093-16) |
NDC Code | 60432-093-16 |
Proprietary Name | Amantadine Hydrochloride |
Package Description | 473 mL in 1 BOTTLE, PLASTIC (60432-093-16) |
Product NDC | 60432-093 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AMANTADINE HYDROCHLORIDE |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 19981224 |
Marketing Category Name | ANDA |
Labeler Name | Morton Grove Pharmaceuticals, Inc. |
Substance Name | AMANTADINE HYDROCHLORIDE |
Strength Number | 50 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |